Our previous studies showed that up-regulation of fibroblast growth factor (FGF)15/19 signaling and its receptors FGFR4/beta-klotho in NASH-HCC mice and in HCC patients 6, 7. Here, FGFR4 is linked to hepatocellular carcinoma.